APA (7th ed.) Citation

Duranti, S., Lombardi, P., Falcone, R., Filetti, M., Pietragalla, A., Sterbini, F. P., . . . Daniele, G. (2021). 1845P Features of clinical trials leading to oncologic drugs approval in europe. Annals of Oncology, 32, S1244. https://doi.org/10.1016/j.annonc.2021.08.733

Chicago Style (17th ed.) Citation

Duranti, S., et al. "1845P Features of Clinical Trials Leading to Oncologic Drugs Approval in Europe." Annals of Oncology 32 (2021): S1244. https://doi.org/10.1016/j.annonc.2021.08.733.

MLA (9th ed.) Citation

Duranti, S., et al. "1845P Features of Clinical Trials Leading to Oncologic Drugs Approval in Europe." Annals of Oncology, vol. 32, 2021, p. S1244, https://doi.org/10.1016/j.annonc.2021.08.733.